GAROFALO, MARIANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.274
EU - Europa 235
AS - Asia 182
OC - Oceania 2
Totale 2.693
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.272
IT - Italia 148
CN - Cina 130
GB - Regno Unito 26
VN - Vietnam 25
FI - Finlandia 21
IR - Iran 19
DE - Germania 10
FR - Francia 7
IE - Irlanda 6
UA - Ucraina 5
HK - Hong Kong 4
AT - Austria 3
NL - Olanda 3
SE - Svezia 3
IN - India 2
NZ - Nuova Zelanda 2
SG - Singapore 2
BE - Belgio 1
CA - Canada 1
CR - Costa Rica 1
ES - Italia 1
GR - Grecia 1
Totale 2.693
Salva come PNG Salva come JPEG
Città #
Fairfield 508
Seattle 224
Ashburn 216
Woodbridge 211
Cambridge 177
Houston 170
Wilmington 134
Chandler 116
Ann Arbor 89
Padova 71
San Diego 55
Medford 45
Princeton 45
Beijing 32
Des Moines 28
Dong Ket 25
Boardman 20
Helsinki 19
Jinan 14
Shenyang 12
London 11
Roxbury 11
Nanjing 9
Milan 7
Dearborn 6
Dublin 6
Hebei 6
Guangzhou 5
Haikou 5
Nanchang 5
Changsha 4
Falls Church 4
Hangzhou 4
Hong Kong 4
Kharkiv 4
Ningbo 4
Strasbourg 4
Zhengzhou 4
Bresso 3
Hefei 3
Kunming 3
Shanghai 3
Tappahannock 3
Arzignano 2
Borås 2
Campobasso 2
Chicago 2
Chivasso 2
Kilburn 2
Lanzhou 2
Norwalk 2
Redmond 2
Reggio Nell'emilia 2
Singapore 2
Arre 1
Auckland 1
Bari 1
Chengdu 1
Este 1
Fuzhou 1
Guiyang 1
Huzhou 1
Innsbruck 1
Jiaxing 1
Kraainem 1
Lappeenranta 1
Las Vegas 1
Leiden 1
Limbiate 1
Mahbubnagar 1
Napoli 1
Nashville 1
New Bedfont 1
New Delhi 1
New York 1
Ospedaletto Euganeo 1
Paraparaumu 1
Piraeus 1
Ponte San Nicolò 1
Redwood City 1
San José 1
Schio 1
Selvazzano Dentro 1
Taizhou 1
Valencia 1
Wuhan 1
Xian 1
Totale 2.384
Salva come PNG Salva come JPEG
Nome #
Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model 122
Physical PEGylation to Prevent Insulin Fibrillation 113
Antitumor effect of oncolytic virus and paclitaxel encapsulated in extracellular vesicles for lung cancer treatment 110
408. Oncolytic Vaccines in Combination with PD-L1 Blockade for the Treatment of Melanoma 101
Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma 88
The evolution of adenoviral vectors through genetic and chemical surface modifications 86
Oncolytic adenovirus loaded with L-carnosine as novel strategy to enhance the antitumor activity 86
220. Evaluation of the Efficacy of a New Oncolytic Vaccine Platform in Humanized Mice 83
Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity 80
Systemic Administration and Targeted Delivery of Immunogenic Oncolytic Adenovirus Encapsulated in Extracellular Vesicles for Cancer Therapies 78
Heterologous and cross-species tropism of cancer-derived extracellular vesicles 78
71. Boosting the Immunogenicity of an Oncolytic Vaccinia Virus By Expression of DAI Can Enhance Anti-Tumor Immunity in Humanized Mice 76
661. Synergistic Anti-Tumor Efficacy of Immunogenic Adenovirus ONCOS-102 and Standard of Care Chemotherapy in Preclinical Mesothelioma Model 75
622. Oncolytic Adenoviruses Loaded With Active Drugs as a Novel Drug Delivery System for Cancer Therapy 74
Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice. 73
A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma 72
Thermosensitive "Smart" Surfaces for Biorecognition Based Cell Adhesion and Controlled Detachment 72
The Anti-Proliferative Effect of L-Carnosine Correlates with a Decreased Expression of Hypoxia Inducible Factor 1 alpha in Human Colon Cancer Cells 70
Dexamethasone loaded liposomes by thin‐film hydration and microfluidic procedures: Formulation challenges 67
Optimization of Early Steps in Oncolytic Adenovirus ONCOS-401 Production in T-175 and HYPERFlasks 67
Isoflavones in aglycone solution enhance ultraviolet B-induced DNA damage repair efficiency 64
Antitumor-specific T-cell responses induced by oncolytic adenovirus ONCOS-102 (AdV5/3-D24-GM-CSF) in peritoneal mesothelioma mouse model 63
Oncolytic adenoviruses coated with MHC-I tumor epitopes for a new oncolytic vaccine platform 62
From Conventional Therapies to Immunotherapy: Melanoma Treatment in Review 58
Oncolytic adenovirus loaded with L-carnosine as a drug delivery system for cancer therapy 57
Cancer-derived EVs show tropism for tissues at early stage of neoplastic transformation 56
Inhibition of SIRT1 deacetylase and p53 activation uncouples the anti-inflammatory and chemopreventive actions of NSAIDs 53
How Computational Chemistry and Drug Delivery Techniques Can Support the Development of New Anticancer Drugs 49
PEG-polyaminoacid based micelles for controlled release of doxorubicin: Rational design, safety and efficacy study 49
L-Carnosine and Human Colon Cancer 48
Glabrescione B delivery by self-assembling micelles efficiently inhibits tumor growth in preclinical models of Hedgehog-dependent medulloblastoma 47
Transplantation of autologous extracellular vesicles for cancer-specific targeting 46
Polymer coated oncolytic adenovirus to selectively target hepatocellular carcinoma cells 46
Doxorubicin liposomes cell penetration enhancement and its potential drawbacks for the tumor targeting efficiency 45
Circulating extracellular vesicles release oncogenic miR-424 in experimental models and patients with aggressive prostate cancer 40
Screening of chemical linkers for development of pullulan bioconjugates for intravitreal ocular applications 39
Prospects of Replication-Deficient Adenovirus Based Vaccine Development against SARS-CoV-2 38
Combination Therapy of Novel Oncolytic Adenovirus with Anti-PD1 Resulted in Enhanced Anti-Cancer Effect in Syngeneic Immunocompetent Melanoma Mouse Model 36
PCSK9 promotes arterial medial calcification 30
Application of array-CGH analysis in immune-virotherapy approach 24
I Vaccini 24
L-Carnosine inhibits KRAS-mediated HCT116 proliferation, by affecting ROS production and Hypoxia inducible factor (HIF-1) expression 22
MUG Mel3 Cell Lines Reflect Heterogeneity in Melanoma and Represent a Robust Model for Melanoma in Pregnancy 22
Erratum: The anti-proliferative effect of L-carnosine correlates with a decreased expression of hypoxia inducible factor 1 alpha in human colon cancer cells (PLoS ONE (2014) 9, 5 (e96755) DOI: 10.1371/journal.pone.0096755) 21
Oncologia 11
Focused Design of Novel Cyclic Peptides Endowed with GABARAP-Inhibiting Activity 9
The Multifaceted Roles of Mast Cells in Immune Homeostasis, Infections and Cancers 8
From Immunosuppression to Immunomodulation – Turning Cold Tumours into Hot 7
Structural basis for specific inhibition of salicylate synthase from Mycobacterium abscessus 5
Novel Insights Into Mesothelioma Therapy: Emerging Avenues and Future Prospects 5
Novel combinatorial therapy of oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L with anti PD-1 exhibits enhanced anti-cancer efficacy through promotion of intratumoral T-cell infiltration and modulation of tumour microenvironment in mesothelioma mouse model 1
In vitro immune evaluation of adenoviral vector-based platform for infectious diseases 1
Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model 1
Computational Design of Novel Cyclic Peptides Endowed with Autophagy-Inhibiting Activity on Cancer Cell Lines 1
Totale 2.759
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.878
article - articoli 11.400
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 389
Totale 23.667
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020863 53 44 0 31 63 66 79 118 133 170 58 48
2020/2021718 48 77 48 27 70 16 69 82 82 70 86 43
2021/2022663 13 37 76 60 59 27 27 134 80 13 22 115
2022/2023335 73 1 4 23 70 46 1 38 46 3 15 15
2023/2024180 10 44 38 19 9 10 18 17 8 6 1 0
Totale 2.759